XORTX Therapeutics, Inc. (XRTX)

1.70 -0.01 (-0.58%) USD  |  NASDAQ  |  Sep 29, 16:00
1.58 -0.12 (-7.06%) After-Hours: 20:00
More

XORTX Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for XRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) Upgrade
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade